Concepedia

Agnes Bosch

AB

22

Publications

837

Citations

14

H-Index

2017

Active since

Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg(Current)

Universitätsklinikum Erlangen

Paracelsus Medizinische Privatuniversität

University of Warmia and Mazury in Olsztyn

IPPMed (Germany)

Agnes Bosch is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, end-stage renal disease, and ophthalmology.

ORCID

Top concepts

Publications per year

2017–2023

22

Publications

22

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial

Marina V. Karg, Agnes Bosch, Dennis Kannenkeril et al. · Cardiovascular Diabetology · 2018 · 180 citations · Full text

How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial

Agnes Bosch, Christian Ott, Susanne Jung et al. · Cardiovascular Diabetology · 2019 · 109 citations · Full text

Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications

David E. Kandzari, Raymond R. Townsend, Kazuomi Kario et al. · Journal of the American College of Cardiology · 2023 · 93 citations

Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure

Robert Pietschner, Julie Kolwelter, Agnes Bosch et al. · Cardiovascular Diabetology · 2021 · 64 citations · Full text

The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial

Julie Kolwelter, Dennis Kannenkeril, Peter Linz et al. · Clinical Research in Cardiology · 2022 · 57 citations · Full text

Rows per page

1–5 of 22